Global Remdesivir (COVID-19) Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027
Date: Apr-2021 | Id: MACRC-65980 | Geographical Scope: Global | Publisher: Mnemonics Research
The global Remdesivir (COVID-19) market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on Mnemonics Rresearch newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). By Market Verdors: Gilead Sciences Inovio Pharmaceuticals Kelun Pharma Bright Gene Berry Global Group Hainan Haiyao Borui Bio-Pharmaceutical Hunan Warrant Pharmaceutical By Types: 5mg 10mg 50mg 100mg By Applications: Hospital Clinics Drug Store Others Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Remdesivir (COVID-19) Revenue 1.5 Market Analysis by Type 1.5.1 Global Remdesivir (COVID-19) Market Size Growth Rate by Type: 2021 VS 2027 1.5.2 5mg 1.5.3 10mg 1.5.4 50mg 1.5.5 100mg 1.6 Market by Application 1.6.1 Global Remdesivir (COVID-19) Market Share by Application: 2022-2027 1.6.2 Hospital 1.6.3 Clinics 1.6.4 Drug Store 1.6.5 Others 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Remdesivir (COVID-19) Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter’s Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Remdesivir (COVID-19) Market Players Profiles 3.1 Gilead Sciences 3.1.1 Gilead Sciences Company Profile 3.1.2 Gilead Sciences Remdesivir (COVID-19) Product Specification 3.1.3 Gilead Sciences Remdesivir (COVID-19) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.2 Inovio Pharmaceuticals 3.2.1 Inovio Pharmaceuticals Company Profile 3.2.2 Inovio Pharmaceuticals Remdesivir (COVID-19) Product Specification 3.2.3 Inovio Pharmaceuticals Remdesivir (COVID-19) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.3 Kelun Pharma 3.3.1 Kelun Pharma Company Profile 3.3.2 Kelun Pharma Remdesivir (COVID-19) Product Specification 3.3.3 Kelun Pharma Remdesivir (COVID-19) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.4 Bright Gene 3.4.1 Bright Gene Company Profile 3.4.2 Bright Gene Remdesivir (COVID-19) Product Specification 3.4.3 Bright Gene Remdesivir (COVID-19) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 Berry Global Group 3.5.1 Berry Global Group Company Profile 3.5.2 Berry Global Group Remdesivir (COVID-19) Product Specification 3.5.3 Berry Global Group Remdesivir (COVID-19) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 Hainan Haiyao 3.6.1 Hainan Haiyao Company Profile 3.6.2 Hainan Haiyao Remdesivir (COVID-19) Product Specification 3.6.3 Hainan Haiyao Remdesivir (COVID-19) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.7 Borui Bio-Pharmaceutical 3.7.1 Borui Bio-Pharmaceutical Company Profile 3.7.2 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Product Specification 3.7.3 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.8 Hunan Warrant Pharmaceutical 3.8.1 Hunan Warrant Pharmaceutical Company Profile 3.8.2 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Product Specification 3.8.3 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global Remdesivir (COVID-19) Market Competition by Market Players 4.1 Global Remdesivir (COVID-19) Production Capacity Market Share by Market Players (2016-2021) 4.2 Global Remdesivir (COVID-19) Revenue Market Share by Market Players (2016-2021) 4.3 Global Remdesivir (COVID-19) Average Price by Market Players (2016-2021) 5 Global Remdesivir (COVID-19) Production by Regions (2016-2021) 5.1 North America 5.1.1 North America Remdesivir (COVID-19) Market Size (2016-2021) 5.1.2 Remdesivir (COVID-19) Key Players in North America (2016-2021) 5.1.3 North America Remdesivir (COVID-19) Market Size by Type (2016-2021) 5.1.4 North America Remdesivir (COVID-19) Market Size by Application (2016-2021) 5.2 East Asia 5.2.1 East Asia Remdesivir (COVID-19) Market Size (2016-2021) 5.2.2 Remdesivir (COVID-19) Key Players in East Asia (2016-2021) 5.2.3 East Asia Remdesivir (COVID-19) Market Size by Type (2016-2021) 5.2.4 East Asia Remdesivir (COVID-19) Market Size by Application (2016-2021) 5.3 Europe 5.3.1 Europe Remdesivir (COVID-19) Market Size (2016-2021) 5.3.2 Remdesivir (COVID-19) Key Players in Europe (2016-2021) 5.3.3 Europe Remdesivir (COVID-19) Market Size by Type (2016-2021) 5.3.4 Europe Remdesivir (COVID-19) Market Size by Application (2016-2021) 5.4 South Asia 5.4.1 South Asia Remdesivir (COVID-19) Market Size (2016-2021) 5.4.2 Remdesivir (COVID-19) Key Players in South Asia (2016-2021) 5.4.3 South Asia Remdesivir (COVID-19) Market Size by Type (2016-2021) 5.4.4 South Asia Remdesivir (COVID-19) Market Size by Application (2016-2021) 5.5 Southeast Asia 5.5.1 Southeast Asia Remdesivir (COVID-19) Market Size (2016-2021) 5.5.2 Remdesivir (COVID-19) Key Players in Southeast Asia (2016-2021) 5.5.3 Southeast Asia Remdesivir (COVID-19) Market Size by Type (2016-2021) 5.5.4 Southeast Asia Remdesivir (COVID-19) Market Size by Application (2016-2021) 5.6 Middle East 5.6.1 Middle East Remdesivir (COVID-19) Market Size (2016-2021) 5.6.2 Remdesivir (COVID-19) Key Players in Middle East (2016-2021) 5.6.3 Middle East Remdesivir (COVID-19) Market Size by Type (2016-2021) 5.6.4 Middle East Remdesivir (COVID-19) Market Size by Application (2016-2021) 5.7 Africa 5.7.1 Africa Remdesivir (COVID-19) Market Size (2016-2021) 5.7.2 Remdesivir (COVID-19) Key Players in Africa (2016-2021) 5.7.3 Africa Remdesivir (COVID-19) Market Size by Type (2016-2021) 5.7.4 Africa Remdesivir (COVID-19) Market Size by Application (2016-2021) 5.8 Oceania 5.8.1 Oceania Remdesivir (COVID-19) Market Size (2016-2021) 5.8.2 Remdesivir (COVID-19) Key Players in Oceania (2016-2021) 5.8.3 Oceania Remdesivir (COVID-19) Market Size by Type (2016-2021) 5.8.4 Oceania Remdesivir (COVID-19) Market Size by Application (2016-2021) 5.9 South America 5.9.1 South America Remdesivir (COVID-19) Market Size (2016-2021) 5.9.2 Remdesivir (COVID-19) Key Players in South America (2016-2021) 5.9.3 South America Remdesivir (COVID-19) Market Size by Type (2016-2021) 5.9.4 South America Remdesivir (COVID-19) Market Size by Application (2016-2021) 5.10 Rest of the World 5.10.1 Rest of the World Remdesivir (COVID-19) Market Size (2016-2021) 5.10.2 Remdesivir (COVID-19) Key Players in Rest of the World (2016-2021) 5.10.3 Rest of the World Remdesivir (COVID-19) Market Size by Type (2016-2021) 5.10.4 Rest of the World Remdesivir (COVID-19) Market Size by Application (2016-2021) 6 Global Remdesivir (COVID-19) Consumption by Region (2016-2021) 6.1 North America 6.1.1 North America Remdesivir (COVID-19) Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Remdesivir (COVID-19) Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Remdesivir (COVID-19) Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Remdesivir (COVID-19) Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Remdesivir (COVID-19) Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Remdesivir (COVID-19) Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Remdesivir (COVID-19) Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Remdesivir (COVID-19) Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Remdesivir (COVID-19) Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Remdesivir (COVID-19) Consumption by Countries 7 Global Remdesivir (COVID-19) Production Forecast by Regions (2022-2027) 7.1 Global Forecasted Production of Remdesivir (COVID-19) (2022-2027) 7.2 Global Forecasted Revenue of Remdesivir (COVID-19) (2022-2027) 7.3 Global Forecasted Price of Remdesivir (COVID-19) (2022-2027) 7.4 Global Forecasted Production of Remdesivir (COVID-19) by Region (2022-2027) 7.4.1 North America Remdesivir (COVID-19) Production, Revenue Forecast (2022-2027) 7.4.2 East Asia Remdesivir (COVID-19) Production, Revenue Forecast (2022-2027) 7.4.3 Europe Remdesivir (COVID-19) Production, Revenue Forecast (2022-2027) 7.4.4 South Asia Remdesivir (COVID-19) Production, Revenue Forecast (2022-2027) 7.4.5 Southeast Asia Remdesivir (COVID-19) Production, Revenue Forecast (2022-2027) 7.4.6 Middle East Remdesivir (COVID-19) Production, Revenue Forecast (2022-2027) 7.4.7 Africa Remdesivir (COVID-19) Production, Revenue Forecast (2022-2027) 7.4.8 Oceania Remdesivir (COVID-19) Production, Revenue Forecast (2022-2027) 7.4.9 South America Remdesivir (COVID-19) Production, Revenue Forecast (2022-2027) 7.4.10 Rest of the World Remdesivir (COVID-19) Production, Revenue Forecast (2022-2027) 7.5 Forecast by Type and by Application (2022-2027) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027) 7.5.2 Global Forecasted Consumption of Remdesivir (COVID-19) by Application (2022-2027) 8 Global Remdesivir (COVID-19) Consumption Forecast by Regions (2022-2027) 8.1 North America Forecasted Consumption of Remdesivir (COVID-19) by Country 8.2 East Asia Market Forecasted Consumption of Remdesivir (COVID-19) by Country 8.3 Europe Market Forecasted Consumption of Remdesivir (COVID-19) by Countriy 8.4 South Asia Forecasted Consumption of Remdesivir (COVID-19) by Country 8.5 Southeast Asia Forecasted Consumption of Remdesivir (COVID-19) by Country 8.6 Middle East Forecasted Consumption of Remdesivir (COVID-19) by Country 8.7 Africa Forecasted Consumption of Remdesivir (COVID-19) by Country 8.8 Oceania Forecasted Consumption of Remdesivir (COVID-19) by Country 8.9 South America Forecasted Consumption of Remdesivir (COVID-19) by Country 8.10 Rest of the world Forecasted Consumption of Remdesivir (COVID-19) by Country 9 Global Remdesivir (COVID-19) Sales by Type (2016-2027) 9.1 Global Remdesivir (COVID-19) Historic Market Size by Type (2016-2021) 9.2 Global Remdesivir (COVID-19) Forecasted Market Size by Type (2022-2027) 10 Global Remdesivir (COVID-19) Consumption by Application (2016-2027) 10.1 Global Remdesivir (COVID-19) Historic Market Size by Application (2016-2021) 10.2 Global Remdesivir (COVID-19) Forecasted Market Size by Application (2022-2027) 11 Global Remdesivir (COVID-19) Manufacturing Cost Analysis 11.1 Remdesivir (COVID-19) Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Remdesivir (COVID-19) 12 Global Remdesivir (COVID-19) Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Remdesivir (COVID-19) Distributors List 12.3 Remdesivir (COVID-19) Customers 12.4 Remdesivir (COVID-19) Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Related reports
Pharmaceutical Grade Sodium Chloride Market
$2850-$4575
Adenosine Triphosphate ATP Test Kit Market
$3300-$7000
Alpha 1 Antitrypsin Deficiency Treatment Market
$3300-$7000